reviewTop 1% cited
High density lipoproteins and coronary heart disease
Atherosclerosis · 1996 · Vol. 121(1) · pp. 1–12
Philip J. Barter✉(Royal Adelaide Hospital)Kerry‐Anne Rye(Royal Adelaide Hospital)
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsParaoxonase enzyme and polymorphismsCardiologyCoronary heart diseaseInternal medicineMedicine
MeSH terms
AnimalsAnticholesteremic AgentsArteriosclerosisCholestyramine ResinClinical Trials as TopicCoronary DiseaseDiabetes Mellitus, Type 2HumansHyperlipidemiasLipoproteins, HDLCholesterol, HDLMice, TransgenicRisk FactorsGene ExpressionComorbidity
Citations
378
FWCI
27.44
field-weighted impact
References
107
Percentile
100%
vs. same field & year
Citations per year
Cited by
Cholesteryl Ester Transfer Protein
Arteriosclerosis Thrombosis and Vascular Biology · 2003 · 855 citations
Antiinflammatory Properties of HDL
Circulation Research · 2004 · 1,351 citations
References
Beyond Cholesterol
New England Journal of Medicine · 1989 · 6,424 citations
Molecular physiology of reverse cholesterol transport.
Journal of Lipid Research · 1995 · 1,449 citations
Secretory products of macrophages.
Journal of Clinical Investigation · 1987 · 2,642 citations
Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
Atherosclerosis · 1993 · 813 citations
Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study
American Heart Journal · 1985 · 672 citations
Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
FEBS Letters · 1991 · 975 citations
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Circulation · 1989 · 3,179 citations
High density lipoprotein as a protective factor against coronary heart disease
The American Journal of Medicine · 1977 · 5,061 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.